Neogenomics Inc (NEO) · Peers
Neogenomics against the 17 other companies here in its SEC industry, SIC 873x (the wider group: its own four-digit code has fewer than five). Each figure is the one on the company's own page; the median is the peers', and the rank is among all 18, highest first.
Measure by measure
| Measure | NEO | Peer median | Rank |
|---|---|---|---|
| Market value | $2.17B | median $356.55M | 7 of 17 |
| Forward P/E | 89.8× | median 31.6× | 1 of 8 |
| P/S | 2.9× | median 4.3× | 12 of 16 |
| FCF yield | -0.2% | median -1.3% | 9 of 17 |
| Gross margin | 43.2% | median 29.6% | 5 of 10 |
| Operating margin | -14.2% | median -4.9% | 9 of 16 |
| Net margin | -13.3% | median -15.9% | 8 of 15 |
| ROIC | -10.0% | median 0.4% | 8 of 12 |
| ROE | -12.0% | median -12.7% | 8 of 15 |
| Revenue growth (4y, yearly) | 10.7% | median 1.3% | 5 of 13 |
| Current ratio | 4.4× | median 1.6× | 4 of 18 |
| Stock pay / revenue | 5.4% | median 3.4% | 8 of 17 |
| Share count change | 1.1% | median 1.3% | 9 of 17 |
Green where Neogenomics is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| NEONeogenomics Inc | $2.17B | P/E – | -10.0% | 4.4 |
| IQVIQVIA Holdings Inc | $44.55B | P/E 32.2× | 8.6% | 5.0 |
| INCYIncyte Corporation | $22.59B | P/E 15.8× | 73.6% | 7.4 |
| MEDPMedpace Holdings, Inc. | $17.26B | P/E 35.1× | – | 6.5 |
| ULSUL Solutions Inc. | $14.74B | P/E 29.2× | 26.9% | 5.4 |
| CRLCharles River Laboratories | $14.33B | P/E – | 0.4% | 3.9 |
| ICLRIcon PLC | $13.03B | P/E 307.7× | 2.2% | 4.9 |
| OABIOmniAb, Inc. | $667.34M | P/E – | -18.3% | 3.8 |
| NRCNational Research Corp | $445.71M | P/E 81.6× | 12.0% | 4.0 |
| ONMDOneMedNet Corp | $267.38M | P/E – | – | 2.9 |
| MXCTMaxcyte, Inc. | $134.17M | P/E – | -62.2% | 4.3 |
| BIAFbioAffinity Technologies, Inc. | $30.22M | P/E – | -505.1% | 3.6 |
| VSBCVitaspring Biomedical Co. Ltd. | $26.33M | P/E – | – | 2.3 |
| AIDX20/20 Biolabs, Inc. | $3.33M | P/E – | – | 4.7 |
| CBIHCannabis Bioscience International Holdings, Inc. | $2.33M | P/E – | – | 2.3 |
| ISPCiSpecimen Inc. | $2.31M | P/E – | – | 3.7 |
| FOXOFoxo Technologies Inc. | $182,393 | P/E – | -5.5% | 4.2 |
| ABSIAbsci Corp | – | P/E – | -220.9% | 3.1 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.